Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Long-Term Debt Repayments (2018 - 2024)

Cytosorbents' Long-Term Debt Repayments history spans 3 years, with the latest figure at $4.4 million for Q2 2024.

  • Quarterly results put Long-Term Debt Repayments at $4.4 million for Q2 2024, changed N/A from a year ago — trailing twelve months through Dec 2024 was $5.0 million (changed N/A YoY), and the annual figure for FY2024 was $5.0 million, changed.
  • Long-Term Debt Repayments for Q2 2024 was $4.4 million at Cytosorbents, up from $625000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $15.0 million in Q4 2020 to a low of $625000.0 in Q1 2024.